Overview

A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

Status:
Completed

Trial end date:
2020-03-23

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the bioequivalence of the newly formulated Tylenol tablet (acetaminophen 650 mg) with respect to the Tylenol 8 Hour (H) Extended Release (ER) tablet (acetaminophen 650 mg) in healthy participants under fasting conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Janssen Korea, Ltd., Korea

Treatments:

Acetaminophen